Dr. Raghav Murali-Ganesh BMedSci, MBBS, FRANZCR
Co-Founder & CEO, CancerAid
Dr. Raghav Murali-Ganesh is the Co-Founder & CEO of CancerAid. Completing his Medical Training in the UK, Raghav moved to Sydney, Australia completing his specialist qualifications in Radiation Oncology with a focus on skin and head & neck cancers at RPA & Royal North Shore Hospitals.
Raghav has the ambition of improving healthcare outcomes with the use of digital tools and was drawn towards founding CancerAid in 2016 with a clear mission to improve the outcomes for individuals impacted by cancer.
Since launch, CancerAid has scaled globally with 300% + growth in the last 12-18 months alone. Having achieved 3 capital raises and now support leading organisations across the US, Australia & New Zealand.
Having received prestigious honours including an appearance on Shark Tank 2017, Emerging Company of the year 2017 (AusBiotech / Johnson & Johnson), Best Global Startup (Sir Richard Branson), Best Startup creating Social impact (Steve Wozniak) and the EY Accelerating Entrepreneur award for recognition towards the initiative in creating CancerAid as an innovative healthcare solution to change cancer care on a global scale.
Raghav holds an Bachelor of Medical Science (BMedSci) and MBBS (MD) from the University of Nottingham and fellowship in Radiation Oncology from the Royal Australian College of Radiologists (FRANZCR).
CancerAid
CancerAid is a digital health company that empowers people and organizations impacted by cancer to thrive.
- Since 2019, CancerAid has commercialised a digital coaching platform to 50+ blue-chip customers including disability insurers (FidelityLife, AIA, MLC, AMP) and leading employers (e.g. IBM, Coca-Cola, Lendlease, MinterEllison, Aon, Aus Government)
- CancerAid has begun procurement with a Fortune 100 insurer and committed pilots with 3 of the top 10 disability insurers.
- CancerAid has published commercial evidence of 10:1 ROI for cost savings in improving Return to Work and improved QoL